{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T19:19:44Z","timestamp":1792783184114,"version":"4.5.0"},"reference-count":77,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,5,14]],"date-time":"2026-05-14T00:00:00Z","timestamp":1778716800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,5,14]],"date-time":"2026-05-14T00:00:00Z","timestamp":1778716800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100005046","name":"Natural Science Foundation of Heilongjiang Province","doi-asserted-by":"publisher","award":["PL2025H283"],"award-info":[{"award-number":["PL2025H283"]}],"id":[{"id":"10.13039\/501100005046","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Youth Talent Cultivation Program of the China Association of Chinese Medicine","award":["202557-011"],"award-info":[{"award-number":["202557-011"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Biol Rep"],"published-print":{"date-parts":[[2026,12]]},"DOI":"10.1007\/s11033-026-11960-2","type":"journal-article","created":{"date-parts":[[2026,5,14]],"date-time":"2026-05-14T12:50:36Z","timestamp":1778763036000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Targeting pyroptosis in metabolic dysfunction-associated steatotic liver disease: from molecular mechanisms to therapeutic innovation"],"prefix":"10.1007","volume":"53","author":[{"given":"Chaofan","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chenyang","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xingmei","family":"Yin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xingxing","family":"Yuan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,5,14]]},"reference":[{"key":"11960_CR1","doi-asserted-by":"publisher","unstructured":"Vettor R, Petroni ML, Dotan I, Lalazar G, Haluzik M, Spearman CW et al (2026) Overcoming the barriers in the screening, diagnosis, and follow-up of patients with metabolic dysfunction-associated steatotic liver disease (MASLD) and metabolic dysfunction-associated steatohepatitis (MASH). Rev Endocr Metab Disord. https:\/\/doi.org\/10.1007\/s11154-026-10027-8 PubMed PMID: 42090077 Epub 2026\/05\/06","DOI":"10.1007\/s11154-026-10027-8"},{"issue":"2","key":"11960_CR2","doi-asserted-by":"publisher","first-page":"100915","DOI":"10.1016\/j.jhepr.2023.100915","volume":"6","author":"C Akbari","year":"2024","unstructured":"Akbari C, Dodd M, Stal P, Nasr P, Ekstedt M, Kechagias S et al (2024) Long-term major adverse liver outcomes in 1,260 patients with non-cirrhotic NAFLD. JHEP Rep 6(2):100915 Epub 2024\/01\/31. https:\/\/doi.org\/10.1016\/j.jhepr.2023.100915","journal-title":"JHEP Rep"},{"key":"11960_CR3","doi-asserted-by":"publisher","unstructured":"Anderson MJ, den Hartigh AB, Fink SL (2023) Molecular Mechanisms of Pyroptosis. Methods Mol Biol. ;2641:1\u201316. Epub 2023\/04\/19. https:\/\/doi.org\/10.1007\/978-1-0716-3040-2_1. PubMed PMID: 37074637IF: NA NA NA","DOI":"10.1007\/978-1-0716-3040-2_1"},{"issue":"4","key":"11960_CR4","doi-asserted-by":"publisher","first-page":"167271","DOI":"10.1016\/j.jmb.2021.167271","volume":"434","author":"J Knorr","year":"2022","unstructured":"Knorr J, Wree A, Feldstein AE (2022) Pyroptosis in Steatohepatitis and Liver Diseases. J Mol Biol 434(4):167271 Epub 2021\/10\/01. https:\/\/doi.org\/10.1016\/j.jmb.2021.167271","journal-title":"J Mol Biol"},{"issue":"1","key":"11960_CR5","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1016\/j.jhep.2020.07.041","volume":"74","author":"S Gaul","year":"2021","unstructured":"Gaul S, Leszczynska A, Alegre F, Kaufmann B, Johnson CD, Adams LA et al (2021) Hepatocyte pyroptosis and release of inflammasome particles induce stellate cell activation and liver fibrosis. J Hepatol 74(1):156\u2013167 PubMed PMID: 32763266; PubMed Central PMCID: PMCPMC7749849","journal-title":"J Hepatol"},{"issue":"1","key":"11960_CR6","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1186\/s43556-024-00179-x","volume":"5","author":"Z Xu","year":"2024","unstructured":"Xu Z, Kombe Kombe AJ, Deng S, Zhang H, Wu S, Ruan J et al (2024) NLRP inflammasomes in health and disease. Mol Biomed 5(1):14 Epub 2024\/04\/22. https:\/\/doi.org\/10.1186\/s43556-024-00179-x","journal-title":"Mol Biomed"},{"issue":"3","key":"11960_CR7","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1002\/JLB.3MR0520-104RR","volume":"109","author":"J Moretti","year":"2021","unstructured":"Moretti J, Blander JM (2021) Increasing complexity of NLRP3 inflammasome regulation. J Leukoc Biol 109(3):561\u2013571 Epub 2020\/06\/13. doi: 10.1002\/JLB.3MR0520-104RR. PubMed PMID: 32531835; PubMed Central PMCID: PMCPMC8985609","journal-title":"J Leukoc Biol"},{"issue":"1","key":"11960_CR8","doi-asserted-by":"publisher","first-page":"e13410","DOI":"10.1111\/imr.13410","volume":"329","author":"S Gupta","year":"2025","unstructured":"Gupta S, Cassel SL, Sutterwala FS, Dagvadorj J (2025) Regulation of the NLRP3 inflammasome by autophagy and mitophagy. Immunol Rev 329(1):e13410 Epub 2024\/10\/17. https:\/\/doi.org\/10.1111\/imr.13410","journal-title":"Immunol Rev"},{"issue":"4","key":"11960_CR9","doi-asserted-by":"publisher","first-page":"167245","DOI":"10.1016\/j.jmb.2021.167245","volume":"434","author":"SS Wright","year":"2022","unstructured":"Wright SS, Vasudevan SO, Rathinam VA (2022) Mechanisms and Consequences of Noncanonical Inflammasome-Mediated Pyroptosis. J Mol Biol 434(4):167245 Epub 2021\/09\/20. https:\/\/doi.org\/10.1016\/j.jmb.2021.167245","journal-title":"J Mol Biol"},{"issue":"7","key":"11960_CR10","doi-asserted-by":"publisher","first-page":"948","DOI":"10.20892\/j.issn.2095-3941","volume":"19","author":"W Wang","year":"2022","unstructured":"Wang W, Zhang L, Sun Z (2022) Eliciting pyroptosis to fuel cancer immunotherapy: mechanisms and strategies. Cancer Biol Med 19(7):948\u2013964 Epub 2022\/07\/21. https:\/\/doi.org\/10.20892\/j.issn.2095-3941","journal-title":"Cancer Biol Med"},{"key":"11960_CR11","doi-asserted-by":"publisher","first-page":"1290885","DOI":"10.3389\/fimmu.2023.1290885","volume":"14","author":"HM You","year":"2023","unstructured":"You HM, Wang L, Meng HW, Huang C, Fang GY, Li J (2023) Pyroptosis: shedding light on the mechanisms and links with cancers. Front Immunol 14:1290885 Epub 2023\/11\/28. https:\/\/doi.org\/10.3389\/fimmu.2023.1290885","journal-title":"Front Immunol"},{"key":"11960_CR12","doi-asserted-by":"publisher","first-page":"101781","DOI":"10.1016\/j.smim.2023.101781","volume":"69","author":"SO Vasudevan","year":"2023","unstructured":"Vasudevan SO, Behl B, Rathinam VA (2023) Pyroptosis-induced inflammation and tissue damage. Semin Immunol 69:101781 Epub 2023\/06\/23. https:\/\/doi.org\/10.1016\/j.smim.2023.101781","journal-title":"Semin Immunol"},{"key":"11960_CR13","doi-asserted-by":"publisher","first-page":"1338125","DOI":"10.3389\/fimmu.2024.1338125","volume":"15","author":"L Ni","year":"2024","unstructured":"Ni L, Chen D, Zhao Y, Ye R, Fang P (2024) Unveiling the flames: macrophage pyroptosis and its crucial role in liver diseases. Front Immunol 15:1338125 Epub 2024\/02\/21. https:\/\/doi.org\/10.3389\/fimmu.2024.1338125","journal-title":"Front Immunol"},{"issue":"9","key":"11960_CR14","doi-asserted-by":"publisher","first-page":"1545","DOI":"10.1038\/s41556-024-01463-2","volume":"26","author":"B Zhou","year":"2024","unstructured":"Zhou B, Jiang ZH, Dai MR, Ai YL, Xiao L, Zhong CQ et al (2024) Full-length GSDME mediates pyroptosis independent from cleavage. Nat Cell Biol 26(9):1545\u20131557 Epub 2024\/07\/13. https:\/\/doi.org\/10.1038\/s41556-024-01463-2","journal-title":"Nat Cell Biol"},{"issue":"1","key":"11960_CR15","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1007\/s10555-025-10251-9","volume":"44","author":"TH Chen","year":"2025","unstructured":"Chen TH, Lin SH, Lee MY, Wang HC, Tsai KF, Chou CK (2025) Mitochondrial alterations and signatures in hepatocellular carcinoma. Cancer Metastasis Rev 44(1):34 Epub 2025\/02\/19. https:\/\/doi.org\/10.1007\/s10555-025-10251-9","journal-title":"Cancer Metastasis Rev"},{"issue":"6","key":"11960_CR16","doi-asserted-by":"publisher","first-page":"110249","DOI":"10.1016\/j.jbc.2025.110249","volume":"301","author":"Z Xu","year":"2025","unstructured":"Xu Z, Tang C, Song X, Liu Z, Zhou J, Shi Q et al (2025) High uric acid exacerbates nonalcoholic steatohepatitis through NLRP3 inflammasome and gasdermin D-mediated pyroptosis. J Biol Chem 301(6):110249 PubMed PMID: 40398602; PubMed Central PMCID: PMCPMC12205687","journal-title":"J Biol Chem"},{"issue":"6","key":"11960_CR17","doi-asserted-by":"publisher","first-page":"814","DOI":"10.1080\/13813455.2023.2288533","volume":"130","author":"Y Zhang","year":"2024","unstructured":"Zhang Y, Han S, Li T, Zhu L, Wei F (2024) Bisphenol A induces non-alcoholic fatty liver disease by promoting the O-GlcNAcylation of NLRP3. Arch Physiol Biochem 130(6):814\u2013822 PubMed PMID: 38038745","journal-title":"Arch Physiol Biochem"},{"issue":"2","key":"11960_CR18","doi-asserted-by":"publisher","first-page":"116942","DOI":"10.1016\/j.celrep.2026.116942","volume":"45","author":"R Duan","year":"2026","unstructured":"Duan R, Wang X, Wang Q, Zhou X, Gao S, Sun Y et al (2026) Hepatocyte PLAGL2 deficiency alleviates MASH through MYD88-licensed inactivation of inflammasome. Cell Rep 45(2):116942 Epub 2026\/02\/14. https:\/\/doi.org\/10.1016\/j.celrep.2026.116942","journal-title":"Cell Rep"},{"key":"11960_CR19","doi-asserted-by":"publisher","unstructured":"Hu PX, Sheng MY, Liu YP, Zhang CQ (2022) FOSL2 deficiency delays nonalcoholic steatohepatitis progression by regulating LY6D-mediated NLRP3 activation. Hum Cell. ;35(6):1752-65. Epub 2022\/08\/06. https:\/\/doi.org\/10.1007\/s13577-022-00760-y. PubMed PMID: 35930135","DOI":"10.1007\/s13577-022-00760-y"},{"issue":"9","key":"11960_CR20","doi-asserted-by":"publisher","first-page":"2026","DOI":"10.12122\/j.issn.1673","volume":"45","author":"S Luo","year":"2025","unstructured":"Luo S, Zhu Q, Yan Y, Ji Z, Zou H, Zhang R et al (2025) [NLRP3 signaling pathway promotes hepatocyte pyroptosis in mice with nonalcoholic steatohepatitis in hypoxic environment]. Nan Fang Yi Ke Da Xue Xue Bao 45(9):2026\u20132033 Epub 2025\/09\/30. https:\/\/doi.org\/10.12122\/j.issn.1673","journal-title":"Nan Fang Yi Ke Da Xue Xue Bao"},{"issue":"5","key":"11960_CR21","doi-asserted-by":"publisher","first-page":"539","DOI":"10.13703\/j.0255-2930.20230206-k0001","volume":"44","author":"X Zhong","year":"2024","unstructured":"Zhong X, Tang C, Yu M (2024) [Regulation of electroacupuncture on non-canonical pathway of hepatocellular pyroptosis in rats with nonalcoholic fatty liver disease]. Zhongguo Zhen Jiu 44(5):539\u2013545 Epub 2024\/05\/20. https:\/\/doi.org\/10.13703\/j.0255-2930.20230206-k0001","journal-title":"Zhongguo Zhen Jiu"},{"issue":"2","key":"11960_CR22","doi-asserted-by":"publisher","first-page":"653","DOI":"10.1016\/j.jcmgh.2021.04.009","volume":"12","author":"Y Zhu","year":"2021","unstructured":"Zhu Y, Zhao H, Lu J, Lin K, Ni J, Wu G et al (2021) Caspase-11-Mediated Hepatocytic Pyroptosis Promotes the Progression of Nonalcoholic Steatohepatitis. Cell Mol Gastroenterol Hepatol 12(2):653\u2013664 PubMed PMID: 33894425; PubMed Central PMCID: PMCPMC8261017","journal-title":"Cell Mol Gastroenterol Hepatol"},{"issue":"4","key":"11960_CR23","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1055\/s-0043-1776773","volume":"43","author":"M Saeidinejad","year":"2023","unstructured":"Saeidinejad M, Elshabrawi A, Sriphoosanaphan S, Andreola F, Mehta G, Agarwal B et al (2023) Novel Therapeutic Approaches in Treatment of Acute-on-Chronic Liver Failure. Semin Liver Dis 43(4):429\u2013445 Epub 2023\/12\/16. https:\/\/doi.org\/10.1055\/s-0043-1776773","journal-title":"Semin Liver Dis"},{"issue":"11","key":"11960_CR24","doi-asserted-by":"publisher","first-page":"3091","DOI":"10.1007\/s00204-022-03344-9","volume":"96","author":"X Mao","year":"2022","unstructured":"Mao X, Li J, Xie X, Chen S, Huang Q, Mu P et al (2022) Deoxynivalenol induces caspase-3\/GSDME-dependent pyroptosis and inflammation in mouse liver and HepaRG cells. Arch Toxicol 96(11):3091\u20133112 Epub 2022\/08\/05. https:\/\/doi.org\/10.1007\/s00204-022-03344-9","journal-title":"Arch Toxicol"},{"key":"11960_CR25","doi-asserted-by":"publisher","first-page":"1113883","DOI":"10.3389\/fimmu.2023.1113883","volume":"14","author":"F Drummer Ct, Saaoud","year":"2023","unstructured":"Drummer Ct, Saaoud F, Jhala NC, Cueto R, Sun Y, Xu K et al (2023) Caspase-11 promotes high-fat diet-induced NAFLD by increasing glycolysis, OXPHOS, and pyroptosis in macrophages. Front Immunol 14:1113883 PubMed PMID: 36776889; PubMed Central PMCID: PMCPMC9909353","journal-title":"Front Immunol"},{"issue":"12","key":"11960_CR26","doi-asserted-by":"publisher","first-page":"1038","DOI":"10.1089\/dna.2022.0265","volume":"41","author":"Q Tang","year":"2022","unstructured":"Tang Q, Liu W, Yang X, Tian Y, Chen J, Hu Y et al (2022) ATG5-Mediated Autophagy May Inhibit Pyroptosis to Ameliorate Oleic Acid-Induced Hepatocyte Steatosis. DNA Cell Biol 41(12):1038\u20131052 Epub 2022\/12\/07. https:\/\/doi.org\/10.1089\/dna.2022.0265","journal-title":"DNA Cell Biol"},{"issue":"2","key":"11960_CR27","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1021\/envhealth.5c00251","volume":"4","author":"W Yan","year":"2026","unstructured":"Yan W, Wang J, Su Y, Zhai X, Zhong Y, Tian L et al (2026) PM(2.5) Induced Iron Accumulation-Associated Hepatocyte Toxicity and Mice Liver Injury via Activation of Ferroptosis and Pyroptosis. Environ Health (Wash) 4(2):225\u2013235 Epub 2026\/02\/26. https:\/\/doi.org\/10.1021\/envhealth.5c00251","journal-title":"Environ Health (Wash)"},{"key":"11960_CR28","doi-asserted-by":"publisher","first-page":"105840","DOI":"10.1016\/j.tiv.2024.105840","volume":"98","author":"X Wang","year":"2024","unstructured":"Wang X, Ye S, Tong L, Gao J, Zhang Y, Qin Y (2024) Inhibition of ROS\/caspase-3\/GSDME-mediated pyroptosis alleviates high glucose-induced injury in AML-12 cells. Toxicol Vitro 98:105840 Epub 2024\/05\/10. https:\/\/doi.org\/10.1016\/j.tiv.2024.105840","journal-title":"Toxicol Vitro"},{"key":"11960_CR29","doi-asserted-by":"publisher","first-page":"116351","DOI":"10.1016\/j.intimp.2026.116351","volume":"174","author":"T Jin","year":"2026","unstructured":"Jin T, Zhao Y, Xu T, Fang Y, Cui Y, Liu W et al (2026) 1-O-acetylbritannilactone alleviates high-fat diet-induced fatty liver by covalently targeting NLRP3. Int Immunopharmacol 174:116351 Epub 2026\/02\/17. https:\/\/doi.org\/10.1016\/j.intimp.2026.116351","journal-title":"Int Immunopharmacol"},{"issue":"2","key":"11960_CR30","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1124\/jpet.123.001639","volume":"386","author":"D Povero","year":"2023","unstructured":"Povero D, Lazic M, McBride C, Ambrus-Aikelin G, Stansfield R, Johnson CD et al (2023) Pharmacology of a Potent and Novel Inhibitor of the NOD-Like Receptor Pyrin Domain-Containing Protein 3 (NLRP3) Inflammasome that Attenuates Development of Nonalcoholic Steatohepatitis and Liver Fibrosis. J Pharmacol Exp Ther 386(2):242\u2013258 Epub 2023\/06\/13. https:\/\/doi.org\/10.1124\/jpet.123.001639","journal-title":"J Pharmacol Exp Ther"},{"key":"11960_CR31","doi-asserted-by":"publisher","first-page":"1563275","DOI":"10.3389\/fphar.2025.1563275","volume":"16","author":"T Yu","year":"2025","unstructured":"Yu T, Xue J, Tang W, Wu X, Li J, Yang F et al (2025) Bletilla striata polysaccharides ameliorate metabolic-associated fatty liver disease by decreasing the NLRP3 inflammasome and pyroptosis. Front Pharmacol 16:1563275 PubMed PMID: 40626309; PubMed Central PMCID: PMCPMC12231352","journal-title":"Front Pharmacol"},{"issue":"2","key":"11960_CR32","doi-asserted-by":"publisher","first-page":"101897","DOI":"10.1016\/j.aohep.2025.101897","volume":"30","author":"LV Marquez-Quiroga","year":"2025","unstructured":"Marquez-Quiroga LV, Barboza-Lopez A, Suarez-Castillo JY, Cardoso-Lezama I, Fuentes-Figueroa MA, Vargas-Pozada EE et al (2025) Naringenin attenuates early hepatocarcinogenesis induced by a MASH model. Ann Hepatol 30(2):101897 Epub 2025\/03\/22. https:\/\/doi.org\/10.1016\/j.aohep.2025.101897","journal-title":"Ann Hepatol"},{"issue":"2","key":"11960_CR33","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1089\/jmf.2023.K.0259","volume":"27","author":"R Luo","year":"2024","unstructured":"Luo R, Hu Y, Wang L, Wang W, Wang P, Ke Z et al (2024) Hesperidin Protects Against High-Fat Diet-Induced Lipotoxicity in Rats by Inhibiting Pyroptosis. J Med Food 27(2):154\u2013166 2023.K.0259. PubMed PMID: 38294790","journal-title":"J Med Food"},{"issue":"3","key":"11960_CR34","doi-asserted-by":"publisher","first-page":"e0301133","DOI":"10.1371\/journal.pone.0301133","volume":"19","author":"S Ran","year":"2024","unstructured":"Ran S, Song L, Yang H, Yu J, Zhen Y, Liu Q (2024) Piperine alleviates nonalcoholic steatohepatitis by inhibiting NF-kappaB-mediated hepatocyte pyroptosis. PLoS ONE 19(3):e0301133 Epub 2024\/03\/28. https:\/\/doi.org\/10.1371\/journal.pone.0301133","journal-title":"PLoS ONE"},{"issue":"2","key":"11960_CR35","doi-asserted-by":"publisher","first-page":"604","DOI":"10.1002\/ptr.8393","volume":"39","author":"J Xu","year":"2025","unstructured":"Xu J, Cheng X, Wang Q, Zhang F, Ren X, Huang K et al (2025) Artemether Ameliorates Non-Alcoholic Steatohepatitis by Restraining Cross-Talk Between Lipotoxicity-Induced Hepatic Hepatocytes and Macrophages. Phytother Res 39(2):604\u2013618 Epub 2024\/11\/29. https:\/\/doi.org\/10.1002\/ptr.8393","journal-title":"Phytother Res"},{"key":"11960_CR36","doi-asserted-by":"publisher","first-page":"109408","DOI":"10.1016\/j.jnutbio.2023.109408","volume":"119","author":"H Han","year":"2023","unstructured":"Han H, Li J, Tian L, Pei L, Zheng M (2023) Through regulation of the SIRT1 pathway plant sterol ester of alpha-linolenic acid inhibits pyroptosis thereby attenuating the development of NASH in mice. J Nutr Biochem 119:109408 Epub 2023\/06\/20. https:\/\/doi.org\/10.1016\/j.jnutbio.2023.109408","journal-title":"J Nutr Biochem"},{"key":"11960_CR37","doi-asserted-by":"publisher","first-page":"116952","DOI":"10.1016\/j.biopha.2024.116952","volume":"177","author":"Q Yong","year":"2024","unstructured":"Yong Q, Huang C, Chen B, An J, Zheng Y, Zhao L et al (2024) Gentiopicroside improves NASH and liver fibrosis by suppressing TLR4 and NLRP3 signaling pathways. Biomed Pharmacother 177:116952 Epub 2024\/06\/26. https:\/\/doi.org\/10.1016\/j.biopha.2024.116952","journal-title":"Biomed Pharmacother"},{"key":"11960_CR38","doi-asserted-by":"publisher","first-page":"175270","DOI":"10.1016\/j.ejphar.2022.175270","volume":"934","author":"H Shi","year":"2022","unstructured":"Shi H, Qiao F, Lu W, Huang K, Wen Y, Ye L et al (2022) Baicalin improved hepatic injury of NASH by regulating NRF2\/HO-1\/NRLP3 pathway. Eur J Pharmacol 934:175270 Epub 2022\/10\/04. https:\/\/doi.org\/10.1016\/j.ejphar.2022.175270","journal-title":"Eur J Pharmacol"},{"issue":"3","key":"11960_CR39","doi-asserted-by":"publisher","first-page":"e0045","DOI":"10.1097\/HC9.0000000000000045","volume":"7","author":"S Huang","year":"2023","unstructured":"Huang S, Wu B, He Y, Qiu R, Yang T, Wang S et al (2023) Canagliflozin ameliorates the development of NAFLD by preventing NLRP3-mediated pyroptosis through FGF21-ERK1\/2 pathway. Hepatol Commun 7(3):e0045 PubMed PMID: 36757426; PubMed Central PMCID: PMCPMC9916118","journal-title":"Hepatol Commun"},{"issue":"1","key":"11960_CR40","doi-asserted-by":"publisher","first-page":"34309","DOI":"10.1038\/s41598-025-11135-2","volume":"15","author":"ZH Eldken","year":"2025","unstructured":"Eldken ZH, Youssef OM, Khalil RM, Kassab AAM, Ramadan A, Sakr NH (2025) Curcumin\u2019s dual effect on pyroptosis and autophagy in metabolic- associated fatty liver disease: a potential therapeutic strategy. Sci Rep 15(1):34309 Epub 2025\/10\/03. https:\/\/doi.org\/10.1038\/s41598-025-11135-2","journal-title":"Sci Rep"},{"issue":"1","key":"11960_CR41","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1186\/s12944-023-01787-2","volume":"22","author":"X Chen","year":"2023","unstructured":"Chen X, Xue W, Zhang J, Peng J, Huang W (2023) Ginsenoside Rg1 attenuates the NASH phenotype by regulating the miR-375-3p\/ATG2B\/PTEN-AKT axis to mediate autophagy and pyroptosis. Lipids Health Dis 22(1):22 Epub 2023\/02\/11. https:\/\/doi.org\/10.1186\/s12944-023-01787-2","journal-title":"Lipids Health Dis"},{"issue":"1","key":"11960_CR42","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1186\/s12967-022-03343-5","volume":"20","author":"J Zhu","year":"2022","unstructured":"Zhu J, Wen Y, Zhang Q, Nie F, Cheng M, Zhao X (2022) The monomer TEC of blueberry improves NASH by augmenting tRF-47-mediated autophagy\/pyroptosis signaling pathway. J Transl Med 20(1):128 Epub 2022\/03\/16. https:\/\/doi.org\/10.1186\/s12967-022-03343-5","journal-title":"J Transl Med"},{"key":"11960_CR43","doi-asserted-by":"publisher","first-page":"115457","DOI":"10.1016\/j.jep.2022.115457","volume":"296","author":"H Ye","year":"2022","unstructured":"Ye H, Ma S, Qiu Z, Huang S, Deng G, Li Y et al (2022) Poria cocos polysaccharides rescue pyroptosis-driven gut vascular barrier disruption in order to alleviates non-alcoholic steatohepatitis. J Ethnopharmacol 296:115457 Epub 2022\/06\/27. https:\/\/doi.org\/10.1016\/j.jep.2022.115457","journal-title":"J Ethnopharmacol"},{"key":"11960_CR44","doi-asserted-by":"publisher","first-page":"104924","DOI":"10.1016\/j.critrevonc.2025.104924","volume":"215","author":"Q Chen","year":"2025","unstructured":"Chen Q, Wang J, Li N, Cai H, Lu Y (2025) Crosstalk between ROS and ferroptosis, cuproptosis, and PANoptosis in liver cancer: Mechanisms and therapeutic strategies. Crit Rev Oncol Hematol 215:104924 Epub 2025\/09\/06. https:\/\/doi.org\/10.1016\/j.critrevonc.2025.104924","journal-title":"Crit Rev Oncol Hematol"},{"key":"11960_CR45","doi-asserted-by":"publisher","unstructured":"Chua D, Low ZS, Cheam GX, Ng AS, Tan NS (2022) Utility of Human Relevant Preclinical Animal Models in Navigating NAFLD to MAFLD Paradigm. Int J Mol Sci. ;23(23). Epub 2022\/12\/12. https:\/\/doi.org\/10.3390\/ijms232314762. PubMed PMID: 36499091; PubMed Central PMCID: PMCPMC9737809","DOI":"10.3390\/ijms232314762"},{"key":"11960_CR46","doi-asserted-by":"publisher","unstructured":"Vandereyken K, Sifrim A, Thienpont B, Voet T (2023) Methods and applications for single-cell and spatial multi-omics. Nat Rev Genet. ;24(8):494\u2013515. Epub 2023\/03\/03. https:\/\/doi.org\/10.1038\/s41576-023-00580-2. PubMed PMID: 36864178; PubMed Central PMCID: PMCPMC9979144 single cells), WO\/2014\/053664 (High-throughput genotyping by sequencing low amounts of genetic material) and WO\/2015\/028576 (Haplotyping and copy number typing using polymorphic variant allelic frequencies)","DOI":"10.1038\/s41576-023-00580-2"},{"issue":"27","key":"11960_CR47","doi-asserted-by":"publisher","first-page":"17040","DOI":"10.1021\/acs.jafc.5c05877","volume":"73","author":"C Ma","year":"2025","unstructured":"Ma C, Bao Y, Hereid S, Zhang H, Bai X, Bai Q et al (2025) Mechanistic Elucidation of Tricholoma mongolicum Polysaccharides in Treating MAFLD via Regulation of the Gut Microbiota-Metabolite-Ferroptosis Axis: A Multi-Omics Perspective. J Agric Food Chem 73(27):17040\u201317056 Epub 2025\/06\/26. https:\/\/doi.org\/10.1021\/acs.jafc.5c05877","journal-title":"J Agric Food Chem"},{"key":"11960_CR48","doi-asserted-by":"publisher","first-page":"1184588","DOI":"10.3389\/fphar.2023.1184588","volume":"14","author":"BL Zhang","year":"2023","unstructured":"Zhang BL, Yu P, Su EY, Zhang CY, Xie SY, Yang X et al (2023) Inhibition of GSDMD activation by Z-LLSD-FMK or Z-YVAD-FMK reduces vascular inflammation and atherosclerotic lesion development in ApoE(-\/-) mice. Front Pharmacol 14:1184588 PubMed PMID: 37593179; PubMed Central PMCID: PMCPMC10427923","journal-title":"Front Pharmacol"},{"key":"11960_CR49","doi-asserted-by":"publisher","unstructured":"Panou T, Gouveri E, Rizzo M, Popovic DS, Papanas N (2025) Ferroptosis and pyroptosis in diabetes mellitus: emerging therapeutic potential of GLP-1 receptor agonists. Front Clin Diabetes Healthc 6 :1657710. Epub 2025\/11\/17. https:\/\/doi.org\/10.3389\/fcdhc.2025.1657710","DOI":"10.3389\/fcdhc.2025.1657710"},{"key":"11960_CR50","doi-asserted-by":"publisher","first-page":"178107","DOI":"10.1016\/j.ejphar.2025.178107","volume":"1005","author":"YL Yang","year":"2025","unstructured":"Yang YL, Huang YH (2025) MicroRNA-29a attenuates inflammation and fibrosis in an animal model of NASH through MCJ inhibition and hippo pathway regulation. Eur J Pharmacol 1005:178107 Epub 2025\/09\/05. https:\/\/doi.org\/10.1016\/j.ejphar.2025.178107","journal-title":"Eur J Pharmacol"},{"issue":"2","key":"11960_CR51","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1016\/j.jhep.2025.01.008","volume":"83","author":"S Zhu","year":"2025","unstructured":"Zhu S, Liao L, Zhong Y, Liu Z, Lu J, Yang Z et al (2025) Hepatocellular CMPK2 promotes the development of metabolic dysfunction-associated steatohepatitis. J Hepatol 83(2):383\u2013396 PubMed PMID: 39855350","journal-title":"J Hepatol"},{"issue":"10","key":"11960_CR52","doi-asserted-by":"publisher","first-page":"770","DOI":"10.1038\/s41419-024-07151-1","volume":"15","author":"R Zhao","year":"2024","unstructured":"Zhao R, Guo Z, Lu K, Chen Q, Riaz F, Zhou Y et al (2024) Hepatocyte-specific NR5A2 deficiency induces pyroptosis and exacerbates non-alcoholic steatohepatitis by downregulating ALDH1B1 expression. Cell Death Dis 15(10):770 Epub 2024\/10\/23. https:\/\/doi.org\/10.1038\/s41419-024-07151-1","journal-title":"Cell Death Dis"},{"key":"11960_CR53","doi-asserted-by":"publisher","first-page":"1283170","DOI":"10.3389\/fmmed.2023.1283170","volume":"3","author":"C Theys","year":"2023","unstructured":"Theys C, Vanderhaeghen T, Van Dijck E, Peleman C, Scheepers A, Ibrahim J et al (2023) Loss of PPARalpha function promotes epigenetic dysregulation of lipid homeostasis driving ferroptosis and pyroptosis lipotoxicity in metabolic dysfunction associated Steatotic liver disease (MASLD). Front Mol Med 3:1283170 PubMed PMID: 39086681IF: NA NA NA; PubMed Central PMCID: PMCPMC11285560IF: NA NA NA","journal-title":"Front Mol Med"},{"issue":"1","key":"11960_CR54","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1186\/s40001-024-01817-4","volume":"29","author":"F Chen","year":"2024","unstructured":"Chen F, Xing Y, Chen Z, Chen X, Li J, Gong S et al (2024) Competitive adsorption of microRNA-532-3p by circular RNA SOD2 activates Thioredoxin Interacting Protein\/NLR family pyrin domain containing 3 pathway and promotes pyroptosis of non-alcoholic fatty hepatocytes. Eur J Med Res 29(1):250 Epub 2024\/04\/25. https:\/\/doi.org\/10.1186\/s40001-024-01817-4","journal-title":"Eur J Med Res"},{"key":"11960_CR55","doi-asserted-by":"publisher","first-page":"103114","DOI":"10.1016\/j.redox.2024.103114","volume":"71","author":"Z Miao","year":"2024","unstructured":"Miao Z, Wang W, Miao Z, Cao Q, Xu S (2024) Role of Selenoprotein W in participating in the progression of non-alcoholic fatty liver disease. Redox Biol 71:103114 Epub 2024\/03\/10. https:\/\/doi.org\/10.1016\/j.redox.2024.103114","journal-title":"Redox Biol"},{"issue":"1","key":"11960_CR56","doi-asserted-by":"publisher","first-page":"1","DOI":"10.12122\/j.issn.1673-4254.2024.01","volume":"44","author":"X Kong","year":"2024","unstructured":"Kong X, Zhang T, Zhang Y, Gao L, Wang W, Wang M et al (2024) [Overexpression of lncRNA HEM2M alleviates liver injury in mice with non-alcoholic fatty liver disease]. Nan Fang Yi Ke Da Xue Xue Bao 44(1):1\u20138 Epub 2024\/01\/31. https:\/\/doi.org\/10.12122\/j.issn.1673-4254.2024.01","journal-title":"Nan Fang Yi Ke Da Xue Xue Bao"},{"issue":"8","key":"11960_CR57","doi-asserted-by":"publisher","first-page":"e23719","DOI":"10.1002\/mrd.23719","volume":"91","author":"YQ Su","year":"2024","unstructured":"Su YQ, Lin Y, Huang SJ, Lin YT, Ran J, Yan FF et al (2024) Pyroptosis is involved in maternal nicotine exposure-induced metabolic associated fatty liver disease progression in offspring mice. Mol Reprod Dev 91(8):e23719 Epub 2023\/11\/29. https:\/\/doi.org\/10.1002\/mrd.23719","journal-title":"Mol Reprod Dev"},{"issue":"1","key":"11960_CR58","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1016\/j.clnu.2023.11.004","volume":"43","author":"X Chen","year":"2024","unstructured":"Chen X, Zhou S, Chen Y, Tong K, Huang W (2024) LncRNA MIR22HG\/microRNA-9-3p\/IGF1 in nonalcoholic steatohepatitis, the ceRNA network increases fibrosis by inhibiting autophagy and promoting pyroptosis. Clin Nutr 43(1):52\u201364 004. PubMed PMID: 38011754","journal-title":"Clin Nutr"},{"issue":"49","key":"11960_CR59","doi-asserted-by":"publisher","first-page":"107703","DOI":"10.1007\/s11356-023-29702-3","volume":"30","author":"Y Shi","year":"2023","unstructured":"Shi Y, Qiu T, Wu C, Yuan W, Yao X, Jiang L et al (2023) Filamin A facilitates NLRP3 inflammasome activation during arsenic-induced nonalcoholic steatohepatitis. Environ Sci Pollut Res Int 30(49):107703\u2013107715 Epub 2023\/09\/23 20:42. https:\/\/doi.org\/10.1007\/s11356-023-29702-3","journal-title":"Environ Sci Pollut Res Int"},{"issue":"7","key":"11960_CR60","doi-asserted-by":"publisher","first-page":"1829","DOI":"10.1038\/s41418-023-01183-4","volume":"30","author":"T Chen","year":"2023","unstructured":"Chen T, Meng Y, Zhou Z, Li H, Wan L, Kang A et al (2023) GAS5 protects against nonalcoholic fatty liver disease via miR-28a-5p\/MARCH7\/NLRP3 axis-mediated pyroptosis. Cell Death Differ 30(7):1829\u20131848 Epub 2023\/06\/20. https:\/\/doi.org\/10.1038\/s41418-023-01183-4","journal-title":"Cell Death Differ"},{"issue":"2","key":"11960_CR61","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1038\/s41419-023-05623-4","volume":"14","author":"B Liu","year":"2023","unstructured":"Liu B, Xu J, Lu L, Gao L, Zhu S, Sui Y et al (2023) Metformin induces pyroptosis in leptin receptor-defective hepatocytes via overactivation of the AMPK axis. Cell Death Dis 14(2):82 Epub 2023\/02\/04. https:\/\/doi.org\/10.1038\/s41419-023-05623-4","journal-title":"Cell Death Dis"},{"issue":"1","key":"11960_CR62","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1186\/s12967-022-03692-1","volume":"20","author":"Y Feng","year":"2022","unstructured":"Feng Y, Li W, Wang Z, Zhang R, Li Y, Zang L et al (2022) The p-STAT3\/ANXA2 axis promotes caspase-1-mediated hepatocyte pyroptosis in non-alcoholic steatohepatitis. J Transl Med 20(1):497 Epub 2022\/11\/04. https:\/\/doi.org\/10.1186\/s12967-022-03692-1","journal-title":"J Transl Med"},{"issue":"2","key":"11960_CR63","doi-asserted-by":"publisher","first-page":"639","DOI":"10.1007\/s10753-021-01573-1","volume":"45","author":"X Gao","year":"2022","unstructured":"Gao X, Ruan Y, Zhu X, Lin X, Xin Y, Li X et al (2022) Deoxycholic Acid Promotes Pyroptosis in Free Fatty Acid-Induced Steatotic Hepatocytes by Inhibiting PINK1-Mediated Mitophagy. Inflammation 45(2):639\u2013650 PubMed PMID: 34674097","journal-title":"Inflammation"},{"issue":"6","key":"11960_CR64","doi-asserted-by":"publisher","first-page":"G1034","DOI":"10.1152\/ajpgi.00431.2020","volume":"320","author":"L Xu","year":"2021","unstructured":"Xu L, Zhou J, Che J, Wang H, Yang W, Zhou W et al (2021) Mitochondrial DNA enables AIM2 inflammasome activation and hepatocyte pyroptosis in nonalcoholic fatty liver disease. Am J Physiol Gastrointest Liver Physiol 320(6):G1034\u2013G44 Epub 2021\/03\/18. https:\/\/doi.org\/10.1152\/ajpgi.00431.2020","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"11960_CR65","doi-asserted-by":"publisher","first-page":"116007","DOI":"10.1016\/j.intimp.2025.116007","volume":"169","author":"P Huang","year":"2026","unstructured":"Huang P, Zhu Y, Li Z, Zeng K, Qin L, Hu J et al (2026) Hyperoside attenuates NASH-associated liver fibrosis by modulating Flot2\/TLR4 signaling and pyroptosis. Int Immunopharmacol 169:116007 Epub 2025\/12\/19. https:\/\/doi.org\/10.1016\/j.intimp.2025.116007","journal-title":"Int Immunopharmacol"},{"key":"11960_CR66","doi-asserted-by":"publisher","first-page":"1622178","DOI":"10.3389\/fphar.2025.1622178","volume":"16","author":"R Yuan","year":"2025","unstructured":"Yuan R, Gui M, Huang S, Ciren Y, Zhuoma D, Yang G et al (2025) Sophora moocroftiana seeds ethanol extract regulates NLRP3 inflammasome activation and pyroptosis via ROS\/TXNIP pathway to amelioration of NAFLD in vitro and in vivo. Front Pharmacol 16:1622178 PubMed PMID: 40926986; PubMed Central PMCID: PMCPMC12415560","journal-title":"Front Pharmacol"},{"issue":"5","key":"11960_CR67","doi-asserted-by":"publisher","first-page":"1521","DOI":"10.1142\/S0192415X25500582","volume":"53","author":"N Guo","year":"2025","unstructured":"Guo N, Geng Q, Wang Y, Sun Y, Xu H, Wu S et al (2025) Paeoniflorin Alleviates Metabolic Dysfunction-Associated Fatty Liver Disease by Targeting STING-Mediated Pyroptosis via Inhibiting the NLRP3 Inflammasome. Am J Chin Med 53(5):1521\u20131543 Epub 2025\/07\/25. https:\/\/doi.org\/10.1142\/S0192415X25500582","journal-title":"Am J Chin Med"},{"key":"11960_CR68","doi-asserted-by":"publisher","unstructured":"Jiang P, Liu Y, Liu J, Quan J, Vitamin D (2025) Attenuates Hepatic Sinusoidal Capillarization in Type 2 Diabetes Mellitus- Metabolic Dysfunction-Associated Fatty Liver Disease via Dual Autophagy Activation and Pyroptosis Suppression in Liver Sinusoidal Endothelial Cells. Biomedicines 13(6) Epub 2025\/06\/26. https:\/\/doi.org\/10.3390\/biomedicines13061459","DOI":"10.3390\/biomedicines13061459"},{"key":"11960_CR69","doi-asserted-by":"publisher","first-page":"114177","DOI":"10.1016\/j.intimp.2025.114177","volume":"148","author":"V Wayal","year":"2025","unstructured":"Wayal V, Wang SD, Hsieh CC (2025) Novel bioactive peptides alleviate Western diet-induced MAFLD in C57BL\/6J mice by inhibiting NLRP3 inflammasome activation and pyroptosis via TLR4\/NF-kappaB and Keap1\/Nrf2\/HO-1 signaling pathways. Int Immunopharmacol 148:114177 Epub 2025\/01\/29. https:\/\/doi.org\/10.1016\/j.intimp.2025.114177","journal-title":"Int Immunopharmacol"},{"key":"11960_CR70","doi-asserted-by":"publisher","first-page":"150424","DOI":"10.1016\/j.bbrc.2024.150424","volume":"734","author":"D Mao","year":"2024","unstructured":"Mao D, Guo J, Yang K, Yang F, Peng J, Jia X et al (2024) Mechanism of epigallocatechin gallate in treating non-alcoholic fatty liver disease: Insights from network pharmacology and experimental validation. Biochem Biophys Res Commun 734:150424 Epub 2024\/08\/01. https:\/\/doi.org\/10.1016\/j.bbrc.2024.150424","journal-title":"Biochem Biophys Res Commun"},{"issue":"7","key":"11960_CR71","doi-asserted-by":"publisher","first-page":"5176","DOI":"10.1002\/fsn3.4165","volume":"12","author":"R Luo","year":"2024","unstructured":"Luo R, Hu Y, Wang L, Ke Z, Wang W, Wang P et al (2024) Penthorum chinense Pursh extract ameliorates hepatic steatosis by suppressing pyroptosis via the NLRP3\/Caspase-1\/GSDMD pathway. Food Sci Nutr 12(7):5176\u20135187 Epub 2024\/07\/26. https:\/\/doi.org\/10.1002\/fsn3.4165","journal-title":"Food Sci Nutr"},{"key":"11960_CR72","doi-asserted-by":"publisher","first-page":"155756","DOI":"10.1016\/j.phymed.2024.155756","volume":"130","author":"J Liu","year":"2024","unstructured":"Liu J, Zheng Y, Yang S, Zhang L, Liu B, Zhang J et al (2024) Targeting antioxidant factor Nrf2 by raffinose ameliorates lipid dysmetabolism-induced pyroptosis, inflammation and fibrosis in NAFLD. Phytomedicine 130:155756 Epub 2024\/06\/05. https:\/\/doi.org\/10.1016\/j.phymed.2024.155756","journal-title":"Phytomedicine"},{"issue":"Pt 2","key":"11960_CR73","doi-asserted-by":"publisher","first-page":"117239","DOI":"10.1016\/j.jep.2023.117239","volume":"319","author":"Y Le","year":"2024","unstructured":"Le Y, Guo J, Liu Z, Liu J, Liu Y, Chen H et al (2024) Calenduloside E ameliorates non-alcoholic fatty liver disease via modulating a pyroptosis-dependent pathway. J Ethnopharmacol 319(Pt 2):117239 Epub 2023\/10\/01. https:\/\/doi.org\/10.1016\/j.jep.2023.117239","journal-title":"J Ethnopharmacol"},{"key":"11960_CR74","first-page":"101545","volume":"35","author":"M Mai","year":"2023","unstructured":"Mai M, Wang Y, Luo M, Li Z, Wang D, Ruan Y et al (2023) Silibinin ameliorates deoxycholic acid-induced pyroptosis in steatotic HepG2 cells by inhibiting NLRP3 inflammasome activation. Biochem Biophys Rep 35:101545 PubMed PMID: 37731666; PubMed Central PMCID: PMCPMC10507139","journal-title":"Biochem Biophys Rep"},{"key":"11960_CR75","doi-asserted-by":"publisher","first-page":"115762","DOI":"10.1016\/j.bcp.2023.115762","volume":"216","author":"I Cardoso-Lezama","year":"2023","unstructured":"Cardoso-Lezama I, Fuentes-Figueroa MA, Ramos-Tovar E, Marquez-Quiroga LV, Ortiz-Fernandez A, Vargas-Pozada EE et al (2023) Nicotinic acid attenuates experimental non-alcoholic steatohepatitis by inhibiting the NLRP3 inflammasome\/pyroptosis pathway. Biochem Pharmacol 216:115762 Epub 2023\/08\/22. https:\/\/doi.org\/10.1016\/j.bcp.2023.115762","journal-title":"Biochem Pharmacol"},{"key":"11960_CR76","doi-asserted-by":"publisher","first-page":"175291","DOI":"10.1016\/j.ejphar.2022.175291","volume":"933","author":"ZT Zhang","year":"2022","unstructured":"Zhang ZT, He WJ, Deng SM, Xu SH, Zeng X, Qian ZM et al (2022) Trilobatin alleviates non-alcoholic fatty liver disease in high-fat diet plus streptozotocin-induced diabetic mice by suppressing NLRP3 inflammasome activation. Eur J Pharmacol 933:175291 Epub 2022\/09\/24. https:\/\/doi.org\/10.1016\/j.ejphar.2022.175291","journal-title":"Eur J Pharmacol"},{"key":"11960_CR77","doi-asserted-by":"publisher","unstructured":"Ojaghi S, Eskandari F, Azarkish F, Soltani H, Binayi F, Saeidi B et al (2026) 4-phenylbutyric acid attenuates hepatic ER stress, pyroptosis, and NAFLD in adult rat offspring exposed to a high-fat, high-fructose diet during perinatal and adulthood. Lipids Health Dis. Epub 2026\/02\/25. https:\/\/doi.org\/10.1186\/s12944-026-02882-w. PubMed PMID: 41736066","DOI":"10.1186\/s12944-026-02882-w"}],"container-title":["Molecular Biology Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11033-026-11960-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11033-026-11960-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11033-026-11960-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,14]],"date-time":"2026-05-14T12:50:40Z","timestamp":1778763040000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11033-026-11960-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,14]]},"references-count":77,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,12]]}},"alternative-id":["11960"],"URL":"https:\/\/doi.org\/10.1007\/s11033-026-11960-2","relation":{},"ISSN":["0301-4851","1573-4978"],"issn-type":[{"value":"0301-4851","type":"print"},{"value":"1573-4978","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,14]]},"assertion":[{"value":"17 March 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 May 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 May 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"774"}}